Cargando…
Current regulatory approaches for accessing potential COVID-19 therapies
This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe...
Autores principales: | Halimi, Vesa, Daci, Armond, Stojanovska, Simona, Panovska-Stavridis, Irina, Stevanovic, Milena, Filipce, Venko, Grozdanova, Aleksandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229878/ https://www.ncbi.nlm.nih.gov/pubmed/32454981 http://dx.doi.org/10.1186/s40545-020-00222-6 |
Ejemplares similares
-
The use of remdesivir outside of clinical trials during the COVID-19 pandemic
por: Halimi, Vesa, et al.
Publicado: (2020) -
Prevalence of Allelic Variants and Clonality of IGHV1-69 Expressing B-Cells in Patients with Different Severity of COVID 19 Disease
por: Panovska-Stavridis, Irina, et al.
Publicado: (2021) -
A Rare Case of Superior Ophthalmic Vein Thrombosis and Thrombocytopenia Following ChAdOx1 nCoV-19 Vaccine Against SARS-CoV-2
por: Panovska-Stavridis, Irina, et al.
Publicado: (2021) -
Clinical and Regulatory Concerns of Biosimilars: A Review of Literature
por: Halimi, Vesa, et al.
Publicado: (2020) -
Quantitative and qualitative analysis of the working area obtained by endoscope and microscope in pterional and orbitozigomatic approach to the basilar artery bifurcation using computed tomography based frameless stereotaxy: A cadaver study
por: Filipce, Venko, et al.
Publicado: (2015)